Lemborexant Recruiting Phase 3 Trials for Sleep Initiation and Maintenance Disorders Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04549168A Study of Lemborexant in Chinese Participants With Insomnia Disorder